Halodoc
PrivateLast Round
Series D
Jul 28, 2023
Est. Valuation
$350M
Total Funding Raised
$258M
Company Overview
Halodoc operates in Healthcare & Life Sciences and is based in Indonesia. Its latest recorded funding round was a Series D round in July 2023.
Halodoc is a digital healthcare company that simplifies access to medical services by connecting patients with doctors for online consultations, lab tests, and real-time health advice through various communication methods.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, E-commerce, Pharma Supply Chain
Business Model
B2C
Customer Profile
Marketplace Commission, Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Halodoc Comparables
Compare Halodoc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alodokter | 91% | |
| SehatQ | 88% | |
| Good Doctor Technology | 84% |
For institutional investors. Book with your work email.
Halodoc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 28, 2023 | ||||
| Series C | Apr 21, 2021 | ||||
| Series B Extension | Jul 25, 2019 | ||||
| Series B | Mar 4, 2019 | ||||
| Series A | Sep 9, 2016 | ||||
Seed | Apr 21, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Halodoc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Argor Capital | Series B |
| Temasek | Series C |
| Djarum | Series A, Series C |
| Korea Investment Partners | Series B |
| United Overseas Bank | Series C, Series B |
| Astra Digital | Series C, Series D |
| UOB Venture Management | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
Developing a Generative AI-powered chatbot system in collaboration with Shurutech.
- Oct 8, 2025
Partnered with Shurutech to design and test a Generative AI chatbot.
For institutional investors. Book with your work email.
Halodoc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Halodoc's valuation, stock price, and market status.
Is Halodoc a public or private company?
Halodoc is a private company.
What is the current stock price of Halodoc?
Halodoc is a private company, so its shares have no public market price. Caplight tracks Halodoc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Halodoc worth (valuation)?
Halodoc's valuation is estimated at $350.0M based on funding round data.
Can I buy Halodoc stock?
Halodoc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Halodoc's last funding round?
Halodoc's most recent funding round was Series D on July 28, 2023.
Who are the main investors in Halodoc?
Key investors in Halodoc include United Overseas Bank, Astra Digital, UOB Venture Management, The Bill & Melinda Gates Foundation Trust, Astra International.
Will Halodoc IPO soon?
No public IPO plans have been announced for Halodoc.
How can I track Halodoc secondary market activity?
Caplight tracks bids, offers, and trades in Halodoc's shares on secondary markets.